SIRIC ILIAD’s research on breast cancer in video
Video : Introduction to SIRIC ILIAD’s research work on breast cancer The SIRIC ILIAD Nantes-Angers (Integrated Cancer Research Site) was
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer : The OPALESCENCE study, a collaborative research
Nantes research on astatine in the spotlight
Nantes research on astatine in the spotlight Astatine (At) is the rarest chemical element on Earth, and its 211 isotope
